PRISM MediaWire

Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference

· LP-20 contrast agent designed to diagnose interstitial cystitis and detect bladder cancer

21 August 2024

ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)

New York, NY. August 21, 2024 - PRISM MediaWire - ANEW MEDICAL, INC. (“ANEW” or the “Company”) (NASDAQ: WENA), announced the signing of an exclusive worldwide license agreement with Transfertech Sherbrooke (“TTS”) regarding Nanoject, a needle-free, freeze-dried nanopowde...

21 August 2024

ANEW MEDICAL, INC. Appoints New CFO

New York, NY, August 19, 2024 - PRISM MediaWire - ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S.-based biotechnology company focused on developing cell and gene-based treatments for aging, and age-related diseases, today announced the appointment of ...

19 August 2024

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Top Line Data Expected Year-End 2024

12 August 2024

ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides

· Melanocortin receptors on neurons in the brain control feeding and weight loss

9 August 2024

Oncocyte Announces August Investor Conferences Participation

IRVINE, Calif., August 5, 2024 - PRISM MediaWire - Oncocyte Corp. (Nasdaq: OCX), a molecular diagnostics technology company, today announced that CEO Josh Riggs and CFO Andrea James plan to participate in the following investor conferences in August:

5 August 2024

Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

PITTSBURGH, PA, August 1, 2024 – PRISM MediaWire -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has closed its previously...

1 August 2024

Oncocyte to Announce Second Quarter 2024 Financial Results on August 8

Conference Call and Webcast on Thursday, August 8, 2024 at 2:00 p.m. PT / 5:00 p.m. ET

1 August 2024

Artificial Intelligence:

AI Datacenters and Infrastructure May Be the Next AI Related Play. Here’s Where to Look

New York, July 24, 2024 - PRISM MarketView - As artificial intelligence (AI) continues to grow in significance, the infrastructure supporting AI technologies has also evolved. This also opens a new door for opportunities related to AI as investors look to boost portfolio...

24 July 2024

Halberd Corp’s (OTC: HALB) Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows Promising Phase II Initial Test Results

Jackson Center, PA July 24, 2024 – PRISM MediaWire -- Halberd Corporation (OTC-PINK: "HALB”) has announced encouraging preliminary outcomes from its Phase II testing at Mississippi State University (MSU) of its Tri-AxTM nasal spray, aimed at mitigating the effects of tr...

24 July 2024